The latest data on U.S. health spending are now available on the Health Spending Explorer, an interactive tool that allows users to explore trends in health expenditures by federal and local governments, insurers, service providers, and individuals. Th…
This slideshow looks at past, present and future trends in prescription drug spending with a focus on the role of specialty drugs.
Using data from the Health System Dashboard, a new analysis looks at trends in health spending and outcomes in the United States between 1991 and 2016. While many U.S. health outcomes, like life expectancy and disease burden, have improved, the share o…
Telemedicine has been seen as a way to possibly improve access to care while also lowering costs. New analysis available on the Peterson-Kaiser Health System Tracker finds that the share of large employers offering health plans that cover telemedicine …
This slideshow explores prescription drug spending for people who are covered by large employer health plans.
A new Kaiser Family Foundation brief examines out-of-network claims in large employer plans, and finds that a significant share of inpatient hospital admissions includes bills from out-of-network providers, often leaving patients exposed to “surp…
A new Kaiser Family Foundation analysis of medical bills from large employer plans finds that a significant share of inpatient hospital admissions includes bills from providers not in the health plan’s networks, generally leaving patients subject to hi…
Two new chart collections examine trends in healthcare prices and utilization and compare health spending in the United States with that of other wealthy countries.
This chart collection explores price increases in private insurance for common services over time and finds significant geographic variation in prices. For example, the average price of a full knee replacement for those in large employer plans increase…
This chart collection illustrates that higher prices – more so than utilization – explain the United States’ high health spending relative to other high-income countries. The U.S. has higher prices for most healthcare services and prescription drugs, according to available internationally comparable data. Meanwhile, utilization of several services, including physician consultations and hospital stays, is lower than in many comparable countries. Use of some services, such as C-sections and knee replacements, is higher in the U.S. than in similar countries.
